Agriculture & Agritech Global On demand · 24-48h

Global RNAi-based Biopesticides Market Strategic Research Report

Global RNAi-based Biopesticides Market Strategic Research Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global RNAi-based Biopesticides Market
$1462025
11.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: PIP, Non-PIP

By Application: Farmland, Orchard, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Bayer, Syngenta, Corteva, BASF, JR Simplot, Greenlight Biosciences, RNAissance Ag, Pebble Labs, Renaissance BioScience, AgroSpheres, Silicon Gene, Shanghai Plant Science Biotechnology, Xiaomo Biotech

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 109 pages
Market size 2025
$146
Million USD
Forecast CAGR
11.7%
2025-2032
Forecast 2032
$316.8
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global RNAi-based Biopesticides market size is predicted to grow from US$ 146 million in 2025 to US$ 313 million in 2032; it is expected to grow at a CAGR of 11.7% from 2026 to 2032.

RNA interference (RNAi) is a biotechnology-based approach to developing biopesticides that achieve precise and efficient pest control by targeting key genes in pests. RNAi-based biopesticides introduce specific double-stranded RNA (dsRNA) into the pest organism, disrupting gene expression and consequently inhibiting its growth, development, or survival. This method is highly selective, affecting only the targeted pest species while minimizing impacts on non-target organisms and the environment, making it an eco-friendly solution. RNAi biopesticides have shown significant potential in controlling pests like the corn borer and cotton bollworm, offering a novel tool for resistance management.

RNA interference (RNAi) technology is gaining significant attention in agriculture as an innovative biopesticide approach. These pesticides target specific pest genes, suppressing their growth or reproduction, thereby achieving precise and efficient pest control. Compared to traditional chemical pesticides, RNAi-based biopesticides have minimal impact on the environment and non-target organisms, making them more ecologically compatible. Currently, research and applications focus on controlling pests, pathogens, and plant viruses, with notable advancements in transgenic crop development and topical application techniques. However, due to the technological complexity and stringent regulatory processes, RNAi biopesticides still have limited market penetration.As agriculture increasingly demands sustainability and precision, RNAi biopesticides are seen as a key direction for the future of pesticide technology. Advances in more efficient RNA delivery mechanisms, improved molecular stability, and declining costs will further drive adoption. Additionally, stricter global pesticide regulations and heightened consumer concern for food safety will push the industry towards low-toxicity and high-selectivity products. Cross-disciplinary applications of RNAi in fields like bioinformatics, gene editing, and smart agriculture also open new opportunities for its development.Key drivers for RNAi biopesticides include policy support, growing market demand for green agriculture, and advancements in biotechnology. However, significant challenges remain, including high R&D costs, limitations in target specificity, poor RNA stability in the environment, and public concerns about genetic technologies. Moreover, varying acceptance levels and regulatory frameworks across different regions present additional hurdles to commercialization.

Key Questions Addressed in this Report

What is the 10-year outlook for the global RNAi-based Biopesticides market?

What factors are driving RNAi-based Biopesticides market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do RNAi-based Biopesticides market opportunities vary by end market size?

How does RNAi-based Biopesticides break out by Type, by Application?

This report presents a comprehensive overview of the global RNAi-based Biopesticides market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • PIP
  • Non-PIP

Segment by Application

  • Farmland
  • Orchard
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global RNAi-based Biopesticides market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Farmland, Orchard, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global RNAi-based Biopesticides Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 11.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$146
2025
Forecast
$316.8
2032
CAGR
11.7%
2025–2032
영역들
5
global
Key companies
BayerSyngentaCortevaBASFJR SimplotGreenlight BiosciencesRNAissance AgPebble Labs
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
PIPNon-PIP
By Application
FarmlandOrchardOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 PIP
  • 3.1.3 Non-PIP
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Farmland
  • 4.1.3 Orchard
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Bayer
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Syngenta
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Corteva
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 BASF
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 JR Simplot
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Greenlight Biosciences
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 RNAissance Ag
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Pebble Labs
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Renaissance BioScience
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 AgroSpheres
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Silicon Gene
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Shanghai Plant Science Biotechnology
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Xiaomo Biotech
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global RNAi-based Biopesticides market?
The global RNAi-based Biopesticides market is estimated at US$ 146 million in 2025 (base year) and is projected to reach US$ 313 million by 2032.
What is the forecast CAGR for the RNAi-based Biopesticides market?
The market is expected to grow at a CAGR of 11.7% from 2026 to 2032, expanding from US$ 146 million in 2025 to US$ 313 million in 2032, roughly 2.1 times its base-year value.
What is RNAi-based Biopesticides?
RNA interference (RNAi) is a biotechnology-based approach to developing biopesticides that achieve precise and efficient pest control by targeting key genes in pests. RNAi-based biopesticides introduce specific double-stranded RNA (dsRNA) into the pest organism, disrupting gene expression and consequently inhibiting its growth, development, or survival. This method is highly selective, affecting only the targeted pest species while minimizing impacts on non-target organisms and the environment, making it an eco-friendly solution.
What are the main segments of the RNAi-based Biopesticides market by type?
By type, the market is segmented into PIP and Non-PIP.
Which applications drive demand in the RNAi-based Biopesticides market?
Key applications covered include Farmland, Orchard and Other.
Who are the key players in the RNAi-based Biopesticides market?
Key players profiled include Bayer, Syngenta, Corteva, BASF, JR Simplot, Greenlight Biosciences, RNAissance Ag and Pebble Labs, among 13 companies covered in total.
Which regions and countries are covered for RNAi-based Biopesticides?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the RNAi-based Biopesticides market?
What factors are driving RNAi-based Biopesticides market growth, globally and by region?
What challenges does the RNAi-based Biopesticides market face?
However, significant challenges remain, including high R&D costs, limitations in target specificity, poor RNA stability in the environment, and public concerns about genetic technologies.
Who should buy the RNAi-based Biopesticides market report?
The report is intended for manufacturers and solution providers, distributors and end users in Farmland, Orchard and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the RNAi-based Biopesticides market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.